Survey says public distrust of third-party partnerships on the rise

Share this article:
A survey of public attitudes toward drug company partnerships with nonprofits has found deep skepticism of industry motives. Among respondents to the Envision Solutions survey, 43% said pharmas fund groups like the American Heart Association and the National Kidney Foundation primarily to boost sales of their medicines. The survey suggests a hardening of attitudes toward such partnerships. By contrast, only 10% of respondents to a similar question in a PRWeek/Barkley Public Relations poll last year said pharmas partner with nonprofits primarily to boost profits. Envision Solutions pointed to media coverage of “disease mongering” as a likely factor driving cynicism. The consultancy said the number of reports on that topic increased 775% from 2005 to 2006. The online survey of 1,062 US adults was conducted by polling firm Kelton Research from April 10-13.
Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...